MarketLens MarketLens
US: 2026-08-12 NSE: 2026-08-12 2026-08-12
Neutral
Menu

Stock Lookup

Search by symbol or company name, then inspect the chart and stock properties.

US

RNAC Cartesian Therapeutics, Inc.

TradingView As Of 8/12/26
Analyst Data
Refresh analyst earnings estimates and rating summary for this symbol only.
Close
8.5800
Day %
0.00%
RS
N/A
Ind Rank
#51
RS 1D
N/A
RS 1W
32
RS 1M
38
RS 3M
41
RS 6M
N/A
Consensus Rating
Buy
Current Quarter EPS
-0.84
Next Quarter EPS
-0.86
Current Year EPS
-3.26
Next Year EPS
-3.73
ExchangeUS
Market Cap0 B
52W High11.0000
From 52W High-22.00%
Open8.6000
High8.8300
Low8.4700
OptionsNo
ActiveYes
RS TypeFull
RS Date2026-08-11
Bars Available310
Scanner Hits2
Last Scanner Hit2026-07-06

Recent Scanner History

2 matching / 2 total
Reset
Date Scanner RS
2026-07-06 Extreme Contraction
US_EXTREME_CONTRACTION
73
2026-07-01 Extreme Contraction
US_EXTREME_CONTRACTION
76

Analyst Snapshot

As Of 3/29/26
Consensus Current Quarter EPS Next Quarter EPS Current Year EPS Next Year EPS
Buy -0.84 -0.86 -3.26 -3.73
Based on 6 analysts offering recommendations for 'RNAC'.

Quarterly EPS Forecasts

4 rows
Period Consensus EPS High Low Estimates Revisions
Mar 2026 -0.84 -0.81 -0.88 4
1 0
Jun 2026 -0.86 -0.79 -0.95 3
0 1
Sep 2026 -0.66 -0.52 -0.92 3
1 0
Dec 2026 -0.68 -0.52 -1.00 3
1 0

Yearly EPS Forecasts

4 rows
Period Consensus EPS High Low Estimates Revisions
Dec 2026 -3.26 -2.51 -3.95 7
2 2
Dec 2027 -3.73 -1.96 -4.82 3
1 0
Dec 2028 -3.63 -2.08 -5.18 2
1 0
Dec 2029 -3.48 -2.15 -4.80 2
1 0